Shukra Pharmaceuticals Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Shukra Pharmaceuticals Ltd is ₹ 29.97 as of 12 Jun 15:30 . The P/E Ratio of Shukra Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 34.3 on March 2021 to 66 on March 2026 . This represents a CAGR of 11.53% over 6 years The Market Cap of Shukra Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 43002 crore on March 2021 to ₹ 142845 crore on March 2026 . This represents a CAGR of 22.15% over 6 years The revenue of Shukra Pharmaceuticals Ltd for the Mar '26 is ₹ 7.27 crore as compare to the Dec '25 revenue of ₹ 39.95 crore. This represent the decline of -81.8% The revenue of Torrent Pharmaceuticals Ltd for the Mar '26 is ₹ 4180 crore as compare to the Dec '25 revenue of ₹ 3290 crore. This represent the growth of 27.05% The ebitda of Shukra Pharmaceuticals Ltd for the Mar '26 is ₹ 1.65 crore as compare to the Dec '25 ebitda of ₹ 27.95 crore. This represent the decline of -94.1% The ebitda of Torrent Pharmaceuticals Ltd for the Mar '26 is ₹ 1273 crore as compare to the Dec '25 ebitda of ₹ 1065 crore. This represent the growth of 19.53% The net profit of Shukra Pharmaceuticals Ltd changed from ₹ 3.16 crore to ₹ -1.72 crore over 6 quarters. This represents a CAGR of NaN% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 457 crore to ₹ 364 crore over 8 quarters. This represents a CAGR of -10.75% The Dividend Payout of Shukra Pharmaceuticals Ltd changed from 10.47 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 52.06 % on March 2021 to 58.69 % on March 2026 . This represents a CAGR of 2.02% over 6 years .

About Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Limited, formerly known Relish Pharmaceuticals Limited was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016.
The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The company provides varieties of products to the clientele.
Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.

About Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 15 countries with major setups in the US, Germany and Brazil.

FAQs for the comparison of Shukra Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Shukra Pharmaceuticals Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Shukra Pharmaceuticals Ltd is 1,312 Cr while Market cap of Torrent Pharmaceuticals Ltd is 154,837 Cr

What are the key factors driving the stock performance of Shukra Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Shukra Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Shukra Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd?

As of June 15, 2026, the Shukra Pharmaceuticals Ltd stock price is INR ₹29.97. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹4574.95.

How do dividend payouts of Shukra Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Shukra Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.